Understanding how lens proteins behave and aggregate in the eye
Structure, function and aggregation of lens α-crystallins by CryoEM
This study is looking at special proteins in the eye that help keep your lens clear and prevent cataracts, and it's for anyone interested in how we might find new ways to treat or prevent cataracts as we age.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10904875 on NIH RePORTER |
What this research studies
This research investigates the structure and function of lens α-crystallins, which are proteins that play a crucial role in maintaining lens transparency and preventing cataracts. Using advanced imaging techniques like CryoEM, the team aims to uncover how these proteins aggregate and interact under various conditions. By understanding these processes, the research seeks to identify potential therapeutic targets for preventing or treating age-related cataracts, which can significantly impact vision. The approach combines biophysical principles with molecular biology to explore the complexities of protein behavior in the lens.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of developing age-related cataracts, particularly older adults.
Not a fit: Patients with cataracts caused by trauma or other non-age-related factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating cataracts, improving vision and quality of life for many patients.
How similar studies have performed: Previous research has shown promise in understanding protein aggregation in other contexts, suggesting that this approach may yield valuable insights into cataract formation.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Reichow, Stephen Loen — Oregon Health & Science University
- Study coordinator: Reichow, Stephen Loen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.